KVUE:NYSE
Kenvue Inc
18,01 US$
arrow_upward
+1,41%(+0,25) 1K
18,01 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 14-okt, 16:00:05 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoKVUE tikeri uchun statistika yaratilmoqda...
Ochish
17,92 US$
Yuqori
18,04 US$
Past
17,76 US$
Bozor kapitali
34,59 mlrd
Oʻrtacha hajm
24,20 mln
Hajmi
0,00
Dividend
4,66%
Choraklik dividendlar
0,21 US$
Eks-dividend sanasi
21-sen, 2026
P/E koeffitsiyenti
20,88
52 haftalik eng yuqori
20,13 US$
52 haftalik eng past
14,02 US$
Aksiya boʻyicha daromad
0,86 US$
Beta
0,48
Muomaladagi aksiyalar
1,92 mlrd
Xodimlar soni
22 ming
Ochish
17,92 US$
Yuqori
18,04 US$
Past
17,76 US$
Bozor kapitali
34,59 mlrd
Oʻrtacha hajm
24,20 mln
Hajmi
0,00
Dividend
4,66%
Choraklik dividendlar
0,21 US$
Eks-dividend sanasi
21-sen, 2026
P/E koeffitsiyenti
20,88
52 haftalik eng yuqori
20,13 US$
52 haftalik eng past
14,02 US$
Aksiya boʻyicha daromad
0,86 US$
Beta
0,48
Muomaladagi aksiyalar
1,92 mlrd
Xodimlar soni
22 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
News Corp
·
10 soat oldin
Kenvue Inc. stock rises Wednesday, outperforms market
Reuters
·
1 kun oldin
EU approves Kimberly-Clark's $40 billion Kenvue acquisition
News Corp
·
1 kun oldin
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Profil
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
Kenvue Inc haqida
CEOKirk Perry
Xodimlar soni21,9 ming
Asos solingan2022
Bosh ofislarSummit, N'yu-Jersi, Amerika Qo‘shma Shtatlari
SektorPersonal care products
Veb-saytkenvue.com